A Study of GW842166 in Adults With Osteoarthritis Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

April 30, 2007

Conditions
Osteoarthritis, Knee
Interventions
DRUG

GW842166

Trial Locations (22)

2650

GSK Investigational Site, Hvidovre

5000

GSK Investigational Site, Odense C

10559

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

12051

GSK Investigational Site, Berlin

15006

GSK Investigational Site, A Coruña

15706

GSK Investigational Site, Santiago de Compostela

20249

GSK Investigational Site, Hamburg

28046

GSK Investigational Site, Madrid

45359

GSK Investigational Site, Essen

51069

GSK Investigational Site, Cologne

80333

GSK Investigational Site, Munich

04109

GSK Investigational Site, Leipzg

01762

GSK Investigational Site, Schmiedeberg

Unknown

GSK Investigational Site, Centelles

GSK Investigational Site, Petrer/Alicante

SE-412 55

GSK Investigational Site, Gothenburg

SE-416 85

GSK Investigational Site, Gothenburg

SE-252 78

GSK Investigational Site, Helsingborg

SE-236 51

GSK Investigational Site, Höllviken

SE-17176

GSK Investigational Site, Stocholm

SE-194 89

GSK Investigational Site, Upplands Vasby

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY